Vicore Pharma Holding AB
VCRE | NASDAQ
$9.89
+$0.09 (+0.92%)
Nov 2, 2026, 12:29 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
PE Ratio | -7.53 | -14.62 | -5.15 | -4.36 | -312.49 |
PEG Ratio | -0.12 | 0.24 | 0.28 | 0 | n/a |
PS Ratio | 941.48 | 22.50 | n/a | n/a | n/a |
PB Ratio | 3.28 | n/a | n/a | n/a | n/a |
P/FCF Ratio | -9.56 | -14.91 | -6.33 | -4.14 | -38.79 |
P/OCF Ratio | -9.56 | -14.91 | -6.33 | -4.18 | -38.79 |
OCF/S Ratio | -9.84K | -150.85 | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 10.28 | n/a | n/a | n/a | n/a |
Current Ratio | 10.28 | n/a | n/a | n/a | n/a |
Asset Turnover | 0 | n/a | n/a | n/a | n/a |
Interest Coverage | -7.57K | -23.8K | -160.75K | -36.34K | n/a |
Return on Equity | -43.59% | n/a | n/a | n/a | n/a |
Return on Assets | -39.18% | n/a | n/a | n/a | n/a |
Return on Invested Capital | -41.31% | n/a | n/a | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100% | 100% | n/a | n/a | n/a |
Net Profit Margin | -12.51K% | -154.22% | n/a | n/a | n/a |
Pretax Profit Margin | -12.51K% | -154.45% | n/a | n/a | n/a |
Operating Profit Margin | -11.91K% | -174.09% | n/a | n/a | n/a |
FCF Margin | -9.84K% | -150.85% | n/a | n/a | n/a |
EBITDA Margin | -12.51K% | -152.40% | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove VCRE